A prospective, multicentre, randomized, double-blind, placebo-controlled trial of onabotulinumtoxinA to treat plantarflexor/invertor overactivity after stroke. - Dunne JW; Gracies JM; Hayes M; Zeman B; Singer BJ (Clinical rehabilitation, 2012)